Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 15SYNDAX

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Vietnam Medi-Pharm Expo
Not Confirmed
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 12564590

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4045

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-12-18

blank

02

arrow
Vietnam Medi-Pharm Expo
Not Confirmed
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 12564590

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4327

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-12-18

blank

03

arrow
Vietnam Medi-Pharm Expo
Not Confirmed
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 12564590

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4327

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-12-18

blank

04

arrow
Vietnam Medi-Pharm Expo
Not Confirmed
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 12564590

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4327

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-12-18

blank

05

arrow
Vietnam Medi-Pharm Expo
Not Confirmed
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 12564590

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4045

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-12-18

blank

06

arrow
Vietnam Medi-Pharm Expo
Not Confirmed
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 12564590

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4045

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-12-18

blank

07

arrow
Vietnam Medi-Pharm Expo
Not Confirmed
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 11479557

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4327

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-08

blank

08

arrow
Vietnam Medi-Pharm Expo
Not Confirmed
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 11479557

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4327

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-08

blank

09

arrow
Vietnam Medi-Pharm Expo
Not Confirmed
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 11479557

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4327

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-08

blank

10

arrow
Vietnam Medi-Pharm Expo
Not Confirmed
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

REVUMENIB CITRATE

US Patent Number : 11479557

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 218944

Patent Use Code : U-4045

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-06-08

blank